Longboard Pharmaceuticals... (LBPH)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
59.98
0.00 (0.00%)
At close: Nov 29, 2024, 6:00 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | 5.00K | 5.00K | 1K | n/a |
Gross Profit | -5.00K | -5.00K | -1K | n/a |
Operating Income | -56.76M | -44.80M | -27.84M | -14.40M |
Interest Income | 2.40M | 837.00K | 64.00K | n/a |
Pretax Income | -54.42M | -43.95M | -27.80M | -14.40M |
Net Income | -54.42M | -43.09M | -27.73M | -14.40M |
Selling & General & Admin | 13.01M | 10.16M | 8.06M | 9.77M |
Research & Development | 43.75M | 34.64M | 19.77M | 4.63M |
Other Expenses | n/a | 16.00K | -22.00K | n/a |
Operating Expenses | 56.76M | 44.80M | 27.84M | 14.40M |
Interest Expense | n/a | 837.00K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 56.76M | 44.80M | 27.84M | 14.40M |
Income Tax | n/a | -853.00K | -64.00K | -14.40K |
Shares Outstanding (Basic) | 22.73M | 17.15M | 17.07M | 17.67M |
Shares Outstanding (Diluted) | 22.73M | 17.15M | 17.07M | 17.67M |
EPS (Basic) | -2.39 | -2.51 | -1.62 | -0.82 |
EPS (Diluted) | -2.39 | -2.51 | -1.62 | -0.82 |
EBITDA | -56.75M | -44.79M | -27.84M | -14.40M |
Depreciation & Amortization | 5.00K | 5.00K | 1K | 7.00M |